INHALED THERAPIES FOR TUBERCULOSIS AND OTHER INFECTIOUS DISEASE

Agenda

  Go
  • Monday, October 16, 2017
  •  

    Mycobacterial Landscape

    8:00 AM  -  8:10 AM
    Welcome/Introduction
    Speakers:
    8:10 AM  -  8:40 AM
    Mycobacteria 2017 and Inhaled Therapy
    Speakers:
    8:40 AM  -  9:10 AM
    Molecular Interactions in TB as Targets of Inhaled Therapy
    Speakers:
    9:10 AM  -  9:40 AM
    Evaluating Antimicrobial Peptides for Anti-TB Activity
    Speakers:
    9:40 AM  -  10:10 AM
    Inhaled Therapy for NTMs
    Speakers:
    10:10 AM  -  10:20 AM
    Panel Discussion
     

    Host Response

    10:35 AM  -  11:05 AM
    To Be Determined
    Speakers:
    11:05 AM  -  11:35 AM
    Interactions between the Macrophage and Mycobacterium Tuberculosis: the role of microRNAs
    Speakers:
    11:35 AM  -  12:00 PM
    Spectinamide-1599 as an Aerosol Therapeutic Drug against TB
     

    Inhaled Vaccine

    1:00 PM  -  1:30 PM
    Vaccine Delivery by Inhalation: Evaluation of Aerosol Delivered BCG
    Speakers:
    1:30 PM  -  2:00 PM
    Design and Optimization of a Temperature-Stable BCG Vaccine for Pulmonary Delivery
    Speakers:
    2:00 PM  -  2:30 PM
    Dry Powder Formulation of RNAi Therapeutics for Inhalation
    Speakers:
    2:30 PM  -  2:45 PM
    Moderator's Discussion
     

    Formulations & Devices I

    3:00 PM  -  3:30 PM
    Large Doses, Disposable Devices and One Patient
    Speakers:
    3:30 PM  -  4:00 PM
    Excipients, do we need them for Respirable Particle Construction?
    Speakers:
    4:00 PM  -  4:30 PM
    Combination Therapy for TB Treatment: Pulmonary Administration of Drug-Loaded Nanoparticles
    Speakers:
    4:30 PM  -  4:45 PM
    Rapporteurs' Presentation and Discussion
  • Tuesday, October 17, 2017
  •  

    Formulations & Devices II

    8:00 AM  -  8:30 AM
    Inhaled Pyrazinoic Acid Esters
    Speakers:
    8:30 AM  -  9:00 AM
    Inhaled Liposomal Ciprofloxacin for Severe Chronic Lung Infections – Recent Advances
    Speakers:
    9:00 AM  -  9:30 AM
    Particle Engineering for Lung Delivery of Anti-TB Drugs
    Speakers:
    9:30 AM  -  10:00 AM
    Engineered Microparticles and High Powder Dose Administration
    Speakers:
    10:00 AM  -  10:15 AM
    Rapporteurs' Presentation and Discussion
     

    Inhaled Therapies

    10:30 AM  -  11:00 AM
    Stand-Alone and Adjunct Therapy
    Speakers:
    11:00 AM  -  11:30 AM
    The More the Merrier-- Drug Combinations
    Speakers:
    11:30 AM  -  12:00 PM
    Controlled Delivery to the Deep Lungs: Opportunities and Challenges
    Speakers:
    12:00 PM  -  12:30 PM
    Imaging of Aerosol Drug Delivery to the Lungs
    Speakers:
    12:30 PM  -  12:45 PM
    Rapporteurs' Presentation and Discussion
     

    Clinical Trials

    1:45 PM  -  2:15 PM
    Inhaled Colistin for Highly-Resistant TB: Improved Study Design and Synergy
    Speakers:
    2:15 PM  -  2:45 PM
    Success of Inhaled Therapy in NTM
    Speakers:
    2:45 PM  -  3:15 PM
    Human Studies on Inhaled Gamma Interferon
    Speakers:
    3:15 PM  -  3:45 PM
    Repositioning Colistin and Bacteriophage for Respiratory Infections: In Vitro and Animal Data
    Speakers:
     Optional 
    3:45 PM  -  4:15 PM
    Opportunities for Inhaled Therapies in MDRTB
    Speakers:
    4:15 PM  -  4:30 PM
    Rapporteurs' Presentation and Discussion
Top